Dopavision

Everyone deserves to see the world clearly

Berlin, Germany · Founded 2017

Headquarters
Berlin, Berlin
Founded
2017
Last Round
Series AJul 2021
Rounds
2

About

Dopavision is bringing a new perspective to the world of eye care by combining selective ocular light stimulation with accessible consumer electronics to non-invasively activate the eye's innate signaling pathways. Its lead product, MyopiaX, is a breakthrough technology targeted at children and young adolescents that aims to become the first digital therapy to control childhood myopia. The company's goal is to address a significant global public health issue and empower people to lead a healthier, brighter future.

Summary

Dopavision is a Healthcare company based in Berlin, Germany, founded in 2017. Its most recent funding was a Series A round in Jul 2021. Investors include Boehringer Ingelheim Venture Fund and Seventure Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJul 2021

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dopavision on Indexed.vc
<a href="https://indexed.vc/companies/dopavision"><img src="https://indexed.vc/api/badge/company/dopavision" alt="Dopavision on Indexed.vc" width="260" height="76" /></a>